View Full Paper

Owner Consent Verified
Case Study 4.8

MLOps and Innovation Diffusion among Pharmaceutical Firms — Evidence from North America

7
Pages
APA
Style
~ 7–12 mins
Reading Time
AI Epidemiology Finance
Abstract

This case study investigates “MLOps and Innovation Diffusion among Pharmaceutical Firms — Evidence from North America” using a time-series forecasting. Through a behavioral lens, the analysis integrates multi-source data to derive a stakeholder-aligned blueprint for researchers and practitioners.

Download PDF Order Similar Paper Save

MLOps and Innovation Diffusion among Pharmaceutical Firms — Evidence from North America

ABSTRACT
MLOps and Innovation Diffusion among Pharmaceutical Firms — Evidence from North America is unpacked across themes: equity, ethics, scalability, and change enablement. Limitations and future research paths are noted.
1
Open full preview
Related Papers
Browse all
37 Pages 4.7
Carbon Markets Adoption in Pharmaceutical Firms: Policy And Regulation — Evidence from DACH Region
Cloud Public Policy Epidemiology
View Paper
40 Pages 4.3
Cost–Benefit Analysis in Cloud Computing for Healthcare Providers: A design science research
AIOps FinTech Governance
View Paper
20 Pages 4.5
Cross-Border Trade for K–12 Teachers: Policy And Regulation | Evidence from Benelux
DEI HCI BioMed
View Paper